Skip to menu Skip to content Skip to footer
Honorary Professor Josephine Forbes
Honorary Professor

Josephine Forbes

Email: 

Overview

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Qualifications

  • Bachelor, University of Melbourne
  • Doctor of Philosophy, University of Melbourne

Works

Search Professor Josephine Forbes’s works on UQ eSpace

267 works between 1995 and 2026

141 - 160 of 267 works

2013

Journal Article

Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.

Thallas-Bonke, Vicki, Coughlan, Melinda T, Tan, Adeline LY, Harcourt, Brooke E, Morgan, Philip E, Davies, Michael J, Bach, Leon A, Cooper, Mark E and Forbes, Josephine M (2013). Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.. Nephrology (Carlton, Vic.), 18 (1), 47-56. doi: 10.1111/j.1440-1797.2012.01665.x

Targeting the AGE-RAGE axis improves renal function in the context of a healthy diet low in advanced glycation end-product content.

2013

Journal Article

Brain atrophy in type 2 diabetes: regional distribution and influence on cognition

Moran, Chris, Phan, Thanh G., Chen, Jian, Blizzard, Leigh, Beare, Richard, Venn, Alison, Munch, Gerald, Wood, Amanda G., Forbes, Josephine, Greenaway, Timothy M., Pearson, Susan and Srikanth, Velandai (2013). Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care, 36 (12), 4036-4042. doi: 10.2337/dc13-0143

Brain atrophy in type 2 diabetes: regional distribution and influence on cognition

2013

Conference Publication

Oligosaccharyltransferase-48 as a Novel Mediator of Chronic Kidney Disease in Diabetes

Zhuang, A., Harcourt, B., Sourris, K., Penfold, S., Ward, M., Fotheringham, A., Thorn, P. and Forbes, J. (2013). Oligosaccharyltransferase-48 as a Novel Mediator of Chronic Kidney Disease in Diabetes. WILEY-BLACKWELL.

Oligosaccharyltransferase-48 as a Novel Mediator of Chronic Kidney Disease in Diabetes

2013

Conference Publication

Methylglyoxal induced insulin resistance in podocytes contributes to diabetic kidney disease

Gallo, L. A., Harcourt, B. E., Fotheringham, A. K., McCarthy, D., Penfold, S. A. and Forbes, J. M. (2013). Methylglyoxal induced insulin resistance in podocytes contributes to diabetic kidney disease. 49th Annual Meeting of the European Association for the Study of Diabetes (EASD), Barcelona, Spain, 23 -27 September 2013. Heidelberg, Germany: Springer. doi: 10.1007/s00125-013-3012-z

Methylglyoxal induced insulin resistance in podocytes contributes to diabetic kidney disease

2012

Journal Article

Erratum: methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (Nature Medicine (2012) 18 (926-933))

Bierhaus, Angelika, Fleming, Thomas, Stoyanov, Stoyan, Leffler, Andreas, Babes, Alexandru, Neacsu, Cristian, Sauer, Susanne K., Eberhardt, Mirjam, Schnölzer, Martina, Lasischka, Felix, Neuhuber, Winfried L., Kichko, Tatjana I., Konrade, Ilze, Elvert, Ralf, Mier, Walter, Pirags, Valdis, Lukic, Ivan K., Morcos, Michael, Dehmer, Thomas, Rabbani, Naila, Thornalley, Paul J., Edelstein, Diane, Nau, Carla, Forbes, Josephine, Humpert, Per M., Schwaninger, Markus, Ziegler, Dan, Stern, David M., Cooper, Mark E. ... Nawroth, Peter P. (2012). Erratum: methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (Nature Medicine (2012) 18 (926-933)). Nature Medicine, 18 (9), 1445-1445. doi: 10.1038/nm0912-1445c

Erratum: methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy (Nature Medicine (2012) 18 (926-933))

2012

Journal Article

Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

Low, H., Hoang, A., Forbes, J., Thomas, M., Lyons, J. G., Nestel, P., Bach, L. A. and Sviridov, D. (2012). Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models. Diabetologia, 55 (9), 2513-2521. doi: 10.1007/s00125-012-2570-9

Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models

2012

Journal Article

Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

Bierhaus, Angelika, Fleming, Thomas, Stoyanov, Stoyan, Leffler, Andreas, Babes, Alexandru, Neacsu, Cristian, Sauer, Susanne K., Eberhardt, Mirjam, Schnoelzer, Martina, Lasischka, Felix, Neuhuber, Winfried L., Kichko, Tatjana I., Konrade, Ilze, Elvert, Ralf, Mier, Walter, Pirags, Valdis, Lukic, Ivan K., Morcos, Michael, Dehmer, Thomas, Rabbani, Naila, Thornalley, Paul J., Edelstein, Diane, Nau, Carla, Forbes, Josephine, Humpert, Per M., Schwaninger, Markus, Ziegler, Dan, Stern, David M., Cooper, Mark E. ... Nawroth, Peter P. (2012). Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nature Medicine, 18 (6), 926-933. doi: 10.1038/nm.2750

Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

2012

Journal Article

Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes

Huynh, K., Kiriazis, H., Du, X. -J., Love, J. E., Jandeleit-Dahm, K. A., Forbes, J. M., McMullen, J. R. and Ritchie, R. H. (2012). Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia, 55 (5), 1544-1553. doi: 10.1007/s00125-012-2495-3

Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes

2012

Journal Article

Advanced glycation end products as environmental risk factors for the development of type 1 diabetes

Yap, Felicia Y. T., Kantharidis, Phillip, Coughlan, Melinda T., Slattery, Robyn and Forbes, Josephine M. (2012). Advanced glycation end products as environmental risk factors for the development of type 1 diabetes. Current Drug Targets, 13 (4), 526-540. doi: 10.2174/138945012799499758

Advanced glycation end products as environmental risk factors for the development of type 1 diabetes

2012

Journal Article

Glycation in diabetic nephropathy

Forbes, Josephine M. and Cooper, Mark E. (2012). Glycation in diabetic nephropathy. Amino Acids, 42 (4), 1185-1192. doi: 10.1007/s00726-010-0771-4

Glycation in diabetic nephropathy

2012

Journal Article

Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes

Sourris, Karly C., Harcourt, Brooke E., Tang, Peter H., Morley, Amy L., Karina Huynh, Penfold, Sally A., Coughlan, Melinda T., Cooper, Mark E., Tuong-Vi Nguyen, Ritchie, Rebecca H. and Forbes, Josephine M. (2012). Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes. Free Radical Biology and Medicine, 52 (3), 716-723. doi: 10.1016/j.freeradbiomed.2011.11.017

Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes

2012

Journal Article

Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice

Harcourt, Brooke E., Forbes, Josephine M. and Matthews, Vance B. (2012). Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice. Nephrology, 17 (3), 257-262. doi: 10.1111/j.1440-1797.2011.01547.x

Obesity-induced renal impairment is exacerbated in interleukin-6-knockout mice

2011

Book Chapter

Role of oxidative stress in diabetic nephropathy

Forbes, Josephine M., Coughlan, Melinda T. and Cooper, Mark E. (2011). Role of oxidative stress in diabetic nephropathy. Advances in Pathogenesis of Diabetic Nephropathy. (pp. 199-218) Nova Science Publishers, Inc..

Role of oxidative stress in diabetic nephropathy

2011

Journal Article

Advanced glycation end products are direct modulators of β-cell function

Coughlan, Melinda T., Yap, Felicia Y. T., Tong, David C. K., Andrikopoulos, Sofianos, Gasser, Anna, Thallas-Bonke, Vicki, Webster, Diane E., Miyazaki, Jun-ichi, Kay, Thomas W., Slattery, Robyn M., Kaye, David M., Drew, Brian G., Kingwell, Bronwyn A., Fourlanos, Spiros, Groop, Per-Henrik, Harrison, Leonard C., Knip, Mikael and Forbes, Josephine M. (2011). Advanced glycation end products are direct modulators of β-cell function. Diabetes, 60 (10), 2523-2532. doi: 10.2337/db10-1033

Advanced glycation end products are direct modulators of β-cell function

2011

Journal Article

Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man

Coughlan, Melinda T., Patel, Sheila K., Jerums, George, Penfold, Sally A., Nguyen, Tuong-Vi, Sourris, Karly C., Panagiotopoulos, Sianna, Srivastava, Piyush M., Cooper, Mark E., Burrell, Louise M., MacIsaac, Richard J. and Forbes, Josephine M. (2011). Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man. American Journal of Nephrology, 34 (4), 347-355. doi: 10.1159/000331064

Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man

2011

Conference Publication

Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens

Harcourt, B. E., Coughlan, M. T., Andrikopoulos, S., Thomas, M. C., Bruce, C., Febbraio, M. A., Nawroth, P., Bierhaus, A., Kantharidis, P., Cooper, M. E. and Forbes, J. M. (2011). Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens. WILEY-BLACKWELL.

Regulation of Renal Receptor for Advanced Glycation End Products (Rage) Via Paracrine Estrogens

2011

Conference Publication

Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes

Sourris, K. C., Morley, A. L., Harcourt, B. E., Penfold, S. A., Coughlan, M. T., Nugyen, T-V, Cooper, M. E., Ritchie, R. H. and Forbes, J. M. (2011). Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes. WILEY-BLACKWELL.

Ubiquinone Is Renoprotective in An Experimental Model of Type 2 Diabetes

2011

Journal Article

The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase

Krautwald, Martina, Leech, Dale, Horne, Stacey, Steele, Megan L., Forbes, Josephine, Rahmadi, Anton, Griffith, Renate and Muench, Gerald (2011). The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase. Rejuvenation Research, 14 (4), 383-391. doi: 10.1089/rej.2010.1143

The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase

2011

Journal Article

Targeted reduction of advanced glycation improves renal function in obesity

Harcourt, Brooke E., Sourris, Karly C., Coughlan, Melinda T., Walker, Karen Z., Dougherty, Sonia L., Andrikopoulos, Sofianos, Morley, Amy L., Thallas-Bonke, Vicki, Chand, Vibhasha, Penfold, Sally A., de Courten, Maximilian P. J., Thomas, Merlin C., Kingwell, Bronwyn A., Bierhaus, Angelika, Cooper, Mark E., de Courten, Barbora and Forbes, Josephine M. (2011). Targeted reduction of advanced glycation improves renal function in obesity. Kidney International, 80 (2), 190-198. doi: 10.1038/ki.2011.57

Targeted reduction of advanced glycation improves renal function in obesity

2011

Journal Article

Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes

Coughlan, Melinda T. and Forbes, Josephine M. (2011). Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes. American Journal of Nephrology, 34 (1), 9-17. doi: 10.1159/000328581

Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes

Funding

Current funding

  • 2022 - 2026
    Designing and translating novel therapies for diabetes and kidney disease
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2024 - 2026
    Understanding RAGE Expression and Function in Human T and Dendritic Cells to Refine the Use of RAGE Targeting Therapeutics for Type 1 Diabetes Prevention
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2022 - 2026
    Australian Centre for Accelerating Diabetes Innovations (ACADI) - MTP Connect MRFF TTRA - Administered by University of Melbourne
    University of Melbourne
    Open grant
  • 2021 - 2024
    Innovative delivery methods for the biologic soluble RAGE to prevent Type 1 Diabetes
    JDRF Pilot and Innovation Awards
    Open grant
  • 2019 - 2021
    RAGE as a novel therapeutic target for T1D
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2019
    Dissolution DNP Hyperpolariser
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2019 - 2021
    Preventing progression of diabetic kidney disease by targeting mitochondrial function
    NHMRC Project Grant
    Open grant
  • 2016 - 2017
    Genetic susceptibility to mitochondrial dysfunction as a risk factor for diabetic nephropathy (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2016 - 2018
    Advanced Glycation in the development of T1D (Helmsley Charitable Trust - George Eisenbath nPOD award for team science) - Administered by the University of Miami
    University of Miami
    Open grant
  • 2016 - 2020
    Investigating pathways to alleviate the burden of diabetes and kidney disease
    NHMRC Research Fellowship
    Open grant
  • 2016
    Mitochondrial dysfunction as a mediator of diabetic kidney disease
    Diabetes Australia Research Program
    Open grant
  • 2015 - 2018
    Environmental Determinants of Islet Autoimmunity (ENDIA) (University of Adelaide led JDRF Australian Type 1 Diabetes Clinical Research Network (T1DCRN) RFA )
    University of Adelaide
    Open grant
  • 2015 - 2017
    Kidney energetics in the development of nephropathy in type 1 diabetes (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2015
    Glucose transport in the diabetic kidney
    Diabetes Australia Research Trust
    Open grant
  • 2015 - 2019
    IL-22 as a Suppressor of Pancreatic Beta-Cell Stress and a Treatment for Diabetes
    NHMRC Project Grant
    Open grant
  • 2014 - 2016
    Urinary metabolic profiles as predictors of early diabetic nephropathy
    Kidney Health Australia
    Open grant
  • 2013 - 2014
    Identification of a novel target for the treatment of diabetic kidney disease
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Modern food processing as a contributor to type 1 diabetes
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    NHMRC Research Fellowship (SRF A): Delineating the role of advanced glycation in diabetes and nephropathy
    NHMRC Research Fellowship
    Open grant

Supervision

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Honorary Professor Josephine Forbes's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au